Jan. 9, 2012
/PRNewswire-Asia-FirstCall/ -- 3SBio Inc. (NASDAQ: SSRX) ("3SBio" or "the Company"), a leading
-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced Mr.
, 3SBio's chief financial officer will attend the UBS Greater China Conference 2012 in
January 11, 2012
. A copy of Mr. Tan's presentation will be archived at
under the investor relations section.
About 3SBio Inc.
3SBio is a leading, fully integrated, profitable biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in
. Its focus is on addressing large markets with significant unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. With headquarters and MP-certified manufacturing facilities in
, PRC, 3SBio employs over 800 people. Shares trade in the form of American Depositary Shares (ADSs) on the NASDAQ stock market under the ticker symbol "SSRX". Please see
for more information.
Chief Financial Officer3SBio Inc.Tel: + 86 24 2581-1820
Director of Investor Relations3SBio Inc. Tel: + 852 8191-6991
SOURCE 3SBio Inc.